ConductScience.org, home

Trial · NCT03136445

Results by group78

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
The Proportion of Patients Who Die or Have Bleeding of WHO Grade 2 or Above by WHO Criteria During the First 30 Days From the First Dose of Trial Treatment, or Planned First Dose for Those Participants Who do Not Receive Treatment.
Intervention Arm31.795% Confidence Interval 26.6 to 37.4percentage of participants
The Proportion of Patients Who Die or Have Bleeding of WHO Grade 2 or Above by WHO Criteria During the First 30 Days From the First Dose of Trial Treatment, or Planned First Dose for Those Participants Who do Not Receive Treatment.
Control Arm34.295% Confidence Interval 29.0 to 40.0percentage of participants
Mean (SD) Percentage of Days With WHO Grade 2 Bleeding or Above, Per Participant.Intervention Arm3.1Standard Deviation 9.5percentage of days
Mean (SD) Percentage of Days With WHO Grade 2 Bleeding or Above, Per Participant.Control Arm3.2Standard Deviation 7.8percentage of days
Time to First Episode of Bleeding of WHO Grade 2 or Greater up to Study Day 30.Intervention ArmNAInter-Quartile Range 10.5 to NALower quartile for number of days
Time to First Episode of Bleeding of WHO Grade 2 or Greater up to Study Day 30.Control ArmNAInter-Quartile Range 8.5 to NALower quartile for number of days
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Intervention ArmGrade 07Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Control ArmGrade 06Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Intervention ArmGrade unassigned0Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Control ArmGrade unassigned1Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Intervention ArmGrade 285Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Control ArmGrade 293Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Intervention ArmGrade 30Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Control ArmGrade 33Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Intervention ArmGrade 42Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Control ArmGrade 41Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Intervention ArmGrade 1111Participants
Highest Grade of Bleeding a Patient Experiences up to Study Day 30.Control ArmGrade 1121Participants
Number of Platelet Transfusions Per Patient up to Study Day 30.Intervention Arm3Inter-Quartile Range 1 to 6platelet units
Number of Platelet Transfusions Per Patient up to Study Day 30.Control Arm3Inter-Quartile Range 1 to 6platelet units

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03136445/results